<DOC>
	<DOCNO>NCT00168363</DOCNO>
	<brief_summary>This Study evaluate safety efficacy brimonidine patient glaucoma ocular hypertension</brief_summary>
	<brief_title>Safety Efficacy Brimonidine Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>ocular hypertension glaucoma eye currently treat brimonidine require IOPlowering therapy eye uncontrolled systemic disease know allergy sensitivity brimonidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>